Sponsors
The bill increases federal funding to expand targeted maternal vaccination outreach that should improve maternal and childhood vaccination rates, but it requires modest additional taxpayer funding and careful implementation to avoid administrative strain and erosion of trust in vulnerable communities.
Pregnant and postpartum people — particularly those in racial and ethnic minority groups — will receive increased targeted outreach and vaccination services, improving access to maternal immunization.
Children of vaccinated pregnant and postpartum people are likely to have higher vaccination coverage, lowering childhood disease risk.
Federal public health efforts get more stable funding with an increase from $5 million to $7 million annually for 2027–2031, supporting program delivery at state and local levels.
Targeted outreach focusing on specific groups could undermine trust or raise equity concerns in communities historically mistreated by the medical system if not designed and executed sensitively.
State and local health programs and health systems may need to reallocate staff time and resources to implement new outreach priorities, creating short-term administrative and operational burdens.
Taxpayers will cover modestly higher federal spending — roughly $2 million per year from 2027–2031 — to fund the expanded program.
Based on analysis of 2 sections of legislative text.
Expands federal maternal vaccination outreach and obstetric focus, raises authorized annual funding from $5M to $7M (FY2027–2031), and requires targeted efforts to boost vaccination among pregnant/postpartum people and their children.
Introduced March 19, 2026 by Terri Sewell · Last progress March 19, 2026
Expands and refocuses federal maternal vaccination outreach and funding to increase vaccine coverage among pregnant and postpartum people and their children, with an explicit emphasis on racial and ethnic minority groups. The measure adds obstetric settings to program scope, raises an annual program funding level from $5 million to $7 million for fiscal years 2027–2031, and requires targeted activities to boost maternal and postpartum vaccination rates.